Filana Therapeutics, Inc. (FLNA) Capital expenditures 2016–2025
Filana Therapeutics, Inc. (FLNA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$581,000FY2025 · since FY2016: $75,000 → $581,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $581,000 | +464.1% |
| FY2024 | $103,000 | -75.1% |
| FY2023 | $414,000 | -84.7% |
| FY2022 | $2.7M | -87.8% |
| FY2021 | $22.2M | — |
| FY2019 | $18,000 | — |
| FY2016 | $75,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice